| Self Hypnotic Relaxation As An Adjunct To Local Anesthesia During Large Core Breast Biopsy (NCT00122369) | Beth Israel Deaconess Medical Center | 2002-03-01 |
| A Trial for HER2 Positive Breast Cancer Patients With Metastatic Disease (NCT00191373) | Eli Lilly and Company | 2002-03-01 |
| Phase III, Randomized, Double Blind Trial Low Dose Tamoxifen Versus Placebo in Hormone Replacement Therapy (HRT) Users (NCT01579734) | European Institute of Oncology | 2002-03-01 |
| Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer (NCT00153907) | Dana-Farber Cancer Institute | 2002-03-01 |
| Investigating the Therapeutic Effectiveness of Aloe Barbadensis in Reducing Cutaneous Side-Effects of Radiation Treatment for Breast Cancer. (NCT00156806) | AHS Cancer Control Alberta | 2002-03-01 |
| Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer (NCT00079248) | Institute of Cancer Research, United Kingdom | 2002-03-01 |
| Tamoxifen or Letrozole in Treating Women With Ductal Carcinoma in Situ (NCT00290745) | University of California, San Francisco | 2002-02-19 |
| A Phase III Trial For Patients With Metastatic Breast Cancer (NCT00191152) | Eli Lilly and Company | 2002-02-01 |
| A Study of Herceptin (Trastuzumab) in Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Advanced and/or Metastatic Breast Cancer (NCT02748213) | Hoffmann-La Roche | 2002-02-01 |
| CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer (NCT00033384) | University of Alabama at Birmingham | 2002-02-01 |
| Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer (NCT00036868) | European Organisation for Research and Treatment of Cancer - EORTC | 2002-02-01 |
| Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer (NCT00036790) | University of Wisconsin, Madison | 2002-02-01 |
| Chemotherapy Combined With Gene Therapy in Treating Patients Who Have Stage III or Stage IV Breast Cancer (NCT00044993) | Introgen Therapeutics | 2002-02-01 |
| Diagnostic Procedures in Women With Locally Advanced Breast Cancer Who Are Receiving Chemotherapy Before Breast Cancer Surgery (NCT00033397) | Alliance for Clinical Trials in Oncology | 2002-02-01 |
| Letrozole in Preventing Breast Cancer in Postmenopausal Women (NCT00090857) | Dana-Farber Cancer Institute | 2002-02-01 |
| Paclitaxel With or Without Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer (NCT00028990) | Eastern Cooperative Oncology Group | 2002-01-29 |
| Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer (NCT00206453) | Baylor Breast Care Center | 2002-01-01 |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer (NCT00027534) | Michael Morse, MD | 2002-01-01 |
| Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer (NCT00253539) | The Cleveland Clinic | 2002-01-01 |
| Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients (NCT00504699) | New York Medical College | 2002-01-01 |
| Indole-3-Carbinol in Preventing Breast Cancer in Nonsmoking Women Who Are at High Risk For Breast Cancer (NCT00033345) | University of Kansas Medical Center | 2002-01-01 |
| 6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients (NCT01222052) | Martin-Luther-Universität Halle-Wittenberg | 2002-01-01 |
| Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer (NCT00039520) | Fox Chase Cancer Center | 2002-01-01 |
| Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO) (NCT00795899) | GBG Forschungs GmbH | 2002-01-01 |
| Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer (NCT00039052) | Neurocrine Biosciences | 2002-01-01 |
| An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment (NCT00131612) | AHS Cancer Control Alberta | 2002-01-01 |
| Study on Pre-menopausal Patients With Advanced ER and PR + BC Treated With Arimidex Plus Zoladex (NCT00235937) | AstraZeneca | 2001-12-01 |
| Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Breast Cancer (NCT00032136) | Cancer Research Campaign Clinical Trials Centre | 2001-12-01 |
| Liposomal Doxorubicin and Gemcitabine in Treating Women With Metastatic Breast Cancer (NCT00027989) | Pharmatech Oncology | 2001-12-01 |
| Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases (NCT00072293) | ETOP IBCSG Partners Foundation | 2001-12-01 |
| Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer (NCT00022087) | Alliance for Clinical Trials in Oncology | 2001-12-01 |
| Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer (NCT00049452) | Herbert Irving Comprehensive Cancer Center | 2001-12-01 |
| Morbidity Following the Diagnosis and Treatment of Patients With Breast Cancer (NCT00027105) | National Institutes of Health Clinical Center (CC) | 2001-11-16 |
| Morbidity After Diagnosis and Treatment of Breast Cancer Patients (NCT00027118) | National Institutes of Health Clinical Center (CC) | 2001-11-16 |
| The Incidence of Breast and Other Cancers Among Female Flight Attendants (NCT00342407) | National Cancer Institute (NCI) | 2001-11-06 |
| Docetaxel in Breast Cancer (NCT00312208) | Sanofi | 2001-11-01 |
| A Pilot Clinical Trial With Tocotrienol on Breast Cancer (NCT01157026) | Malaysia Palm Oil Board | 2001-11-01 |
| Phase II Bevacizumab + Tax In Advanced Breast Cancer (NCT00027885) | Case Comprehensive Cancer Center | 2001-11-01 |
| Capecitabine in Treating Women With Advanced or Metastatic Breast Cancer (NCT00026442) | Pharmatech Oncology | 2001-11-01 |
| Vinorelbine in Treating Older Women With Stage IV Breast Cancer (NCT00022152) | Alliance for Clinical Trials in Oncology | 2001-11-01 |
| Weekly Gemcitabine, Epirubicin, and Docetaxel in Locally Advanced or Inflammatory Breast Cancer (NCT00193050) | SCRI Development Innovations, LLC | 2001-11-01 |
| Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer (NCT00045032) | Hoffmann-La Roche | 2001-11-01 |
| A Telephone-Based Prevention Care Manager in Increasing Screening Rates for Breast Cancer, Cervical Cancer, and Colorectal Cancer in Minority and Low-Income Women (NCT00376909) | Dartmouth-Hitchcock Medical Center | 2001-11-01 |
| Comprehensive Screening for Women at High Genetic Risk for Developing Breast Cancer (NCT00255060) | Stanford University | 2001-11-01 |
| A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer (NCT00378313) | NSABP Foundation Inc | 2001-11-01 |
| Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors (NCT00028405) | Light Sciences LLC | 2001-11-01 |
| Erlotinib in Treating Patients With Locally Advanced or Metastatic Breast Cancer (NCT00030537) | National Cancer Institute (NCI) | 2001-11-01 |
| Internet Use Among Women With Recurrent Metastatic Breast Cancer (NCT00770055) | University of Medicine and Dentistry of New Jersey | 2001-11-01 |
| Molecular Genetic Basis of Invasive Breast Cancer Risk Associated With Lobular Carcinoma in Situ (NCT00581750) | Memorial Sloan Kettering Cancer Center | 2001-10-01 |
| Neoadjuvant Herceptin in Patients With Breast Cancer (NCT00133796) | Mothaffar Rimawi | 2001-10-01 |
| Investigating Mechanisms to Explain Age Associated Differences in Quality of Life Among Breast Cancer Patients (NCT00582478) | Memorial Sloan Kettering Cancer Center | 2001-10-01 |
| Digital Mammography Screening Trial (ACRIN6652) (NCT00008346) | American College of Radiology Imaging Network | 2001-10-01 |
| Radiofrequency Ablation in Treating Patients With Early Invasive Breast Cancer or Ductal Carcinoma in Situ (NCT00388115) | University of California, Davis | 2001-10-01 |
| Biological Therapy in Treating Women With Stage IV Breast Cancer (NCT00027807) | Barbara Ann Karmanos Cancer Institute | 2001-10-01 |
| Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Breast Cancer (NCT00030758) | Anglo Celtic Cooperative Oncology Group | 2001-10-01 |
| Nonmyeloablative Allogeneic Transplant (NCT01272817) | Scripps Health | 2001-10-01 |
| S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer (NCT00025493) | SWOG Cancer Research Network | 2001-10-01 |
| Breast-Conserving Therapy Compared With Mastectomy Followed By Radiation Therapy in Treating Women With Locally Advanced Breast Cancer Previously Treated With Chemotherapy (NCT00028704) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-10-01 |
| Positron Emission Tomography Before Surgery in Evaluating Women With Primary or Recurrent Breast Cancer (NCT00039286) | Memorial Sloan Kettering Cancer Center | 2001-10-01 |
| Treatment With Zoledronic Acid in Patients With Breast Cancer, Multiple Myeloma, and Prostate Cancer With Cancer Related Bone Lesions (NCT00029224) | Novartis | 2001-10-01 |
| Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer (NCT00897416) | Fred Hutchinson Cancer Center | 2001-10-01 |
| Bexarotene in Preventing Breast Cancer in Women at Genetic Risk (NCT00055991) | Baylor Breast Care Center | 2001-09-01 |
| Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer (NCT00193024) | SCRI Development Innovations, LLC | 2001-09-01 |
| Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer (NCT00024102) | Alliance for Clinical Trials in Oncology | 2001-09-01 |
| R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy (NCT00028873) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-09-01 |
| Primary Breast Cancer Occurring Concomitant With Pregnancy (NCT00510367) | M.D. Anderson Cancer Center | 2001-08-07 |
| Herbal Therapy in Treating Women With Metastatic Breast Cancer (NCT00028977) | University of California, San Francisco | 2001-08-01 |
| Studying Blood Samples in Women With Breast Cancer or a History of Breast Cancer (NCT00898703) | University of Arizona | 2001-08-01 |
| Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients (NCT00128843) | Spanish Breast Cancer Research Group | 2001-08-01 |
| Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer (NCT00898131) | Northwestern University | 2001-08-01 |
| Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression (NCT00033514) | Jonsson Comprehensive Cancer Center | 2001-08-01 |
| Microwave Thermotherapy in Treating Women With Stage I or Stage II Breast Cancer (NCT00036998) | Imunon | 2001-08-01 |
| Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer (NCT00146549) | Dana-Farber Cancer Institute | 2001-08-01 |
| Combination Chemotherapy With or Without Microwave Thermotherapy Before Surgery in Treating Women With Locally Advanced Breast Cancer (NCT00036985) | Imunon | 2001-08-01 |
| Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples (NCT01034033) | Stanford University | 2001-08-01 |
| Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone Surgery (NCT00039546) | Cancer Research Campaign Clinical Trials Centre | 2001-08-01 |
| Exemestane in Reducing Breast Density in Postmenopausal Women at Risk for Breast Cancer (NCT00066586) | NCIC Clinical Trials Group | 2001-08-01 |
| Combination Chemotherapy in Treating Women With Breast Cancer (NCT00047099) | Ludwig-Maximilians - University of Munich | 2001-08-01 |
| PS-341 in Treating Women With Metastatic Breast Cancer (NCT00028639) | Northwestern University | 2001-08-01 |
| Shark Cartilage in Treating Patients With Advanced Colorectal or Breast Cancer (NCT00026117) | Alliance for Clinical Trials in Oncology | 2001-08-01 |
| Photodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin (NCT00023790) | Case Comprehensive Cancer Center | 2001-08-01 |
| Weekly Gemcitabine and Trastuzumab in the Treatment of Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Metastatic Breast Cancer (NCT00193063) | SCRI Development Innovations, LLC | 2001-07-01 |
| Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease (NCT00813878) | City of Hope Medical Center | 2001-07-01 |
| A Study of Herceptin (Trastuzumab) in Combination Chemotherapy in Patients With Metastatic or Locally Advanced Breast Cancer (NCT02015676) | Hoffmann-La Roche | 2001-07-01 |
| Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients (NCT00841399) | COL George Peoples, MD, FACS | 2001-07-01 |
| Cancer Screening and Prevention Program for High Risk Women (NCT00849199) | NYU Langone Health | 2001-07-01 |
| Gabapentin For the Control of Hot Flashes in Women With Breast Cancer (NCT00022074) | Gary Morrow | 2001-07-01 |
| Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites (NCT00161980) | Baxter Healthcare Corporation | 2001-06-01 |
| Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer (NCT00054587) | UNICANCER | 2001-06-01 |
| Epirubicin and Docetaxel Combination (ET) or Epirubicin Followed by Docetaxel (E/T) for Node Negative (N0) High Risk Breast Cancer Patients (NCT00424606) | Hellenic Oncology Research Group | 2001-06-01 |
| Study of the Effects of Chemotherapy on Memory and Other Mental Functions in Women With Breast Cancer (NCT00260975) | Ottawa Hospital Research Institute | 2001-06-01 |
| Vibro-Acoustography Imaging in Finding Breast Microcalcifications and Lesions in Women (NCT00626119) | Mayo Clinic | 2001-06-01 |
| Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy (NCT00022425) | The Cleveland Clinic | 2001-06-01 |
| Intensity Modulated Radiotherapy With Concomitant Boost in Breast Cancer (NCT03471741) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2001-06-01 |
| Bevacizumab to Treat Inflammatory Breast Cancer or Locally Advanced Breast Cancer (NCT00016549) | National Cancer Institute (NCI) | 2001-05-13 |
| S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer (NCT00016406) | SWOG Cancer Research Network | 2001-05-01 |
| A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemotherapy (NCT00109265) | Genentech, Inc. | 2001-05-01 |
| Cryosurgery in Treating Women With Breast Lesions (NCT00020852) | Jonsson Comprehensive Cancer Center | 2001-05-01 |
| ICI 182780 in Treating Women With Metastatic Breast Cancer (NCT00012025) | Alliance for Clinical Trials in Oncology | 2001-05-01 |
| Preoperative Herceptin and Navelbine for Breast Cancer (NCT00148681) | Dana-Farber Cancer Institute | 2001-05-01 |